Rezurock

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 79802-200
  • Package NDC 79802-200-30
  • Application number NDA214783
  • SPL ID 65249371-3fc5-4a85-a999-9ed367b8dd73
  • SPL set ID 102e4ef4-7f84-4e34-8df1-479c24d1575d
  • UNII 834YJF89WO
  • RxCUI 2564031
  • RxCUI 2564037

What the source publishes

Labeler
Kadmon Pharmaceuticals, LLC
Active ingredients
belumosudil
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:79802-200_65249371-3fc5-4a85-a999-9ed367b8dd73
{
  "name": "Rezurock",
  "splId": "65249371-3fc5-4a85-a999-9ed367b8dd73",
  "labels": [
    {
      "setId": "102e4ef4-7f84-4e34-8df1-479c24d1575d",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=102e4ef4-7f84-4e34-8df1-479c24d1575d",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=102e4ef4-7f84-4e34-8df1-479c24d1575d"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Kadmon Pharmaceuticals, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 BOTTLE in 1 CARTON (79802-200-30)  / 30 TABLET in 1 BOTTLE",
      "package_ndc": "79802-200-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210716"
    }
  ],
  "productId": "79802-200_65249371-3fc5-4a85-a999-9ed367b8dd73",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "79802-200",
  "deaSchedule": null,
  "genericName": "belumosudil",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "BELUMOSUDIL",
      "strength": "200 mg/1"
    }
  ],
  "applicationNumber": "NDA214783",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20210716",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "834YJF89WO"
    ],
    "rxcui": [
      "2564031",
      "2564037"
    ],
    "spl_set_id": [
      "102e4ef4-7f84-4e34-8df1-479c24d1575d"
    ],
    "manufacturer_name": [
      "Kadmon Pharmaceuticals, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:79802-200_65249371-3fc5-4a85-a999-9ed367b8dd73"